Pharmacogenetics

Developing the National Pharmacogenetics Pathway  

A new national Pharmacogenetics Programme has been launched consisting of two key projects which have been developed as part of the Accelerated National Innovation Adoption (ANIA) pathway.  

The initiative is designed to integrate genetic testing into routine clinical care to improve medication safety and effectiveness.   

The programme has been developed in collaboration with NHS Scotland partners with input from geneticists and clinicians.   

The Pharmacogenetics Projects: 

1. Stroke Clopidogrel – CYP2C19 Genotype Testing to identify stroke and Transient Ischemic Attack (TIA) patients who are resistant to Clopidogrel 
2. Neonatal Gentamicin Point of Care Genetic Testing (POCT) to prevent the permanent hearing loss in babies caused by the antibiotic gentamicin